4-bromo-3-(6-hydroxy-1,3-benzodioxol-5-yl)-1-pentyl-1,3-dihydro-2H-indol-2-one → ethyl [5-chloro-3-(6-hydroxy-2,3-dihydro-1-benzofuran-5-yl)-3-(hydroxymethyl)-2-oxo-2,3-dihydro-1H-indol-1-yl]acetate
Reaction equation
BrC1C=CC=C2C=1C(C1C(O)=CC3OCOC=3C=1)[C:5](=[O:16])N2CCCCC.[Cl:27][C:28]1[CH:29]=[C:30]2[C:34](=[CH:35][CH:36]=1)[N:33]([CH2:37][C:38]([O:40][CH2:41][CH3:42])=[O:39])[C:32](=[O:43])[CH:31]2[C:44]1[C:45]([OH:53])=[CH:46][C:47]2[O:51][CH2:50][CH2:49][C:48]=2[CH:52]=1>>[Cl:27][C:28]1[CH:29]=[C:30]2[C:34](=[CH:35][CH:36]=1)[N:33]([CH2:37][C:38]([O:40][CH2:41][CH3:42])=[O:39])[C:32](=[O:43])[C:31]2([C:44]1[C:45]([OH:53])=[CH:46][C:47]2[O:51][CH2:50][CH2:49][C:48]=2[CH:52]=1)[CH2:5][OH:16]Participants
3
Reactant 2
Product 1
Procedure
Following the procedure as described in PREPARATION 1E, and making non-critical variations to replace 4-bromo-3-(6-hydroxy-1,3-benzodioxol-5-yl)-1-pentyl-1,3-dihydro-2H-indol-2-one with ethyl [5-chloro-3-(6-hydroxy-2,3-dihydro-1-benzofuran-5-yl)-2-oxo-2,3-dihydro-1H-indol-1-yl]acetate, the title compound was obtained (99%): MS (ES+) m/z 418.7 (M+1).
Sources & evidence
- ORD record
- ord-cefc6630c2394c0a8719f9b91c1ee6a3
- Source dataset
- uspto-grants-2011_05
- Patent number
- US07935721B2
Reaction notes
Loading…